Top 10 Early Analyst Upgrades & Downgrades (FUL, OZM, REP, TOL, DOV, EMR, GA, GSK, MEDX, RDS-A)
These are ten of the top pre-market early bird upgrades and downgrades we are seeing from analysts this Friday morning: H.B. Fuller (NYSE: FUL) Raised to Overweight at JPMorgan. Och-Ziff Capital (NYSE: OZM) Started as Buy at Jefferies. Repsol YPF…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
These are ten of the top pre-market early bird upgrades and downgrades we are seeing from analysts this Friday morning:
- H.B. Fuller (NYSE: FUL) Raised to Overweight at JPMorgan.
- Och-Ziff Capital (NYSE: OZM) Started as Buy at Jefferies.
- Repsol YPF (NYSE: REP) Raised to Buy from Hold at ING; Raised to Hold from Sell at Soc-Gen.
- Toll Brothers (NYSE: TOL) Started as Outperform at KBW.
- Dover (NYSE: DOV) Cut to Underweight at JPMorgan.
- Emerson Electric (NYSE: EMR) Cut to Underweight at JPMorgan.
- Giant Interactive (NYSE: GA) Cut to Perform at Oppenheimer.
- GlaxoSmithkline (NYSE: GSK) Cut to Neutral from Buy at UBS.
- Medarex (NASDAQ: MEDX) Started as Sell at Merriman Curhan Ford.
- Royal Dutch Shell (NYSE: RDS-A) Cut to Hold from Buy at ING.
Jon C. Ogg
November 14, 2008
Contact [email protected] for any questions or corrections.

